Dr. Spiera Roche/Genentech Dr. Matteson Ardea Sanofi Centocor/Janssen Celgene Amgen Roche Genentech Mesoblast Novartis Pfizer UCB Pharma Dr. Dasgupta Merck Roche Mundipharma Servier   adverse events is usually lower than for efficacy data. This necessitated the use of relevant external evidence to strengthen this aspect of our recommendations. These recommendations should support clinicians to achieve the best patient outcomes. Further research on existing drugs is necessary to offer